Study found drugs used to prevent shingles and treat erectile dysfunction could be promising for Alzheimer’s patients ...
A new study has identified three existing medications that could be repurposed to treat or prevent Alzheimer's disease.
Novo Nordisk will soon announce the results of perhaps the most ambitious studies yet of its GLP-1 drug: whether it can help ...
A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...
Eli Lilly receives CDSCO approval for donanemab, a new Alzheimer's treatment targeting early symptomatic stages of the ...
Investing.com -- Eli Lilly and Company (India) Pvt. has received marketing approval from India’s Central Drugs Standard Control Organization for donanemab, a medication used to treat Alzheimer’s ...
A FREE NHS jab could be the most promising drug yet to stop Alzheimer’s, experts say. The shingles vaccine emerged as the strongest contender after researchers reviewed 80 existing medicines to ...
Scientists tested the substance on rats with positive results and are now seeking partnerships with pharmaceutical companies to conduct clinical trials. A research team at the Federal University of AB ...
4don MSNOpinion
Anavex tumbles as Alzheimer’s therapy faces EU rejection
Anavex Life Sciences (AVXL) stock falls as the company faces a potential failure to win EU approval for its Alzheimer’s ...
The roadmap to fighting Alzheimer’s disease is a matter of updating government policy to match the current science.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results